FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at prediction of unfavourable course of uveal melanoma. Presence of exudate and level of absolute quantity and relative content of T-cytotoxic lymphocytes with phenotype CD3+ CD8+ from total lymphocyte count in peripheral blood are determined. If exudate is present in tumour zone, adjacent area and macula, amount of T-cytotoxic lymphocytes with phenotype CD3+ CD8+ more than 0.4×109/l and relative content more than 22 % unfavourable course is predicted.
EFFECT: use of the declared invention provides selecting a timely, adequate treatment of uveal melanoma.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF INITIAL MELANOMA OF CILIOCHOROIDAL LOCALIZATION AND CHRONIC IRIDOCYCLITIS | 2019 |
|
RU2715678C1 |
| METHOD FOR PREDICTING THE UNFAVORABLE COURSE OF UVEAL MELANOMA ASSOCIATED WITH A MALIGNANT MICROENVIRONMENT | 2019 |
|
RU2709214C1 |
| METHOD FOR PREDICTING THE COURSE OF THE INITIAL CHOROIDAL MELANOMA | 2017 |
|
RU2645644C1 |
| METHOD FOR PREDICTING THE SURVIVAL CAPACITY OF PATIENTS AFTER ENUCLEATION FOR INITIAL CHOROID MELANOMA SPREAD TO THE OPTIC DISC | 2021 |
|
RU2778965C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE COURSE OF INITIAL CHOROID MELANOMA AFTER ORGAN-PRESERVING TREATMENT, BASED ON DETERMINATION OF LEVEL OF TRANSFORMING GROWTH FACTOR TGF-β2 | 2020 |
|
RU2733577C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE COURSE OF CHRONIC POST-TRAUMATIC UVEITIS AFTER SINGLE PENETRATING SURGICAL INTERVENTION ON EYEBALL | 2020 |
|
RU2733745C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PRIMARY MELANOMA AND CHOROID NEVUS | 2018 |
|
RU2689190C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PRIMARY UVEAL MELANOMA AND LOCALIZED CHOROIDAL HEMANGIOMA USING OPTICAL COHERENT TOMOGRAPHY-ANGIOGRAPHY | 2016 |
|
RU2622380C1 |
| METHOD OF REVEALING LATENT METASTATIC SPREAD IN PATIENTS WITH UVEAL MELANOMA | 1998 |
|
RU2147373C1 |
| METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF MELANOMA OF THE CHOROID OF THE CENTRAL LOCALIZATION AND THE LATE STAGE OF AGE-RELATED MACULAR DEGENERATION | 2022 |
|
RU2792554C1 |
